6个月以下婴儿使用丙泊酚进行放射学成像的经验
回顾性分析304例6个月以下接受丙泊酚镇静行放射学成像的婴儿,操作成功率为99%(301/304),12.8%(39/304)发生镇静相关轻微不良事件,4.3%(13/304)发生严重不良事件,以气道梗阻最常见;诱导丙泊酚中位剂量为4.7 mg/kg,53.3%(162/304)的婴儿术中需增加丙泊酚输注速率;未发现镇静相关不良事件的显著预测因素。作者结论认为丙泊酚可用于6个月以下婴儿的放射学成像且成功率高,但 practitioner 应注意剂量需求较高和气道事件发生率较高。
要点
- 6个月以下婴儿丙泊酚镇静行放射学成像成功率为99%(301/304)。
- 12.8%(39/304)发生镇静相关轻微不良事件,4.3%(13/304)发生严重不良事件,气道梗阻最常见。
- 诱导丙泊酚中位剂量4.7 mg/kg,53.3%(162/304)的婴儿术中需增加输注速率。
核心结论
- 丙泊酚可用于6个月以下婴儿的放射学成像且成功率高,但应注意剂量需求较高和气道事件发生率较高,这些事件可由有经验的镇静团队识别和处理。
研究设计与样本
- 回顾性病历审查,纳入2012年10月至2015年2月期间304例接受丙泊酚程序性镇静的6个月以下婴儿,收集患者人口学资料、丙泊酚剂量、镇静相关不良事件和干预措施;严重不良事件定义为喉痉挛、误吸、需入院、心脏骤停或死亡。
诊断标准与关键数值
- 操作成功率为99%(301/304)。
- 镇静相关轻微不良事件共57例次,发生于12.8%(39/304)的患者。
- 严重不良事件共14例次,发生于4.3%(13/304)的患者,气道梗阻最常见。
- 需干预者占18.4%(56/304),最常见的干预为持续气道正压通气(CPAP)25/304(8.2%)和托下颌15/304(4.9%)。
- 诱导丙泊酚中位剂量为4.7 mg/kg;术中需增加丙泊酚输注速率者占53.3%(162/304)。
临床应用与阅片要点
- 作者结论认为丙泊酚可用于6个月以下婴儿的放射学成像且成功率高。
- 作者指出 practitioner 应注意剂量需求较高和气道事件发生率较高,这些事件可由有经验的镇静团队识别和处理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: There is an increased risk associated with procedural sedation of infants younger than 6 months of age. The use of propofol for radiologic imaging of this age group is not well studied.
OBJECTIVE: We hypothesize that adverse events are higher in the infant population receiving propofol for radiologic imaging.
MATERIALS AND METHODS: A retrospective chart review was undertaken of 304 infants younger than 6 months old who received propofol for procedural sedation from October 2012 to February 2015. Patient demographics, propofol dosing, sedation-related adverse events and interventions were collected. Serious adverse events were defined as laryngospasm, aspiration, the need for admission, cardiac arrest or death.
RESULTS: Procedural sedation for radiologic imaging was successful in 301/304 (99%) of infants using propofol. Of these 304 patients, 130 (42.8%) patients were female, and 240 of the 304 (79%) were between 3 and 6 months of age. The majority of patients (172/304 [56.6%]) were American Society of Anesthesiologists-Physical Status Class II. There were 57 sedation-related, minor adverse events in 39 out of 304 (12.8%) patients. Thirteen of the 304 (4.3%) patients had 14 serious adverse events, with airway obstruction the most common. Eighty interventions were required in 56/304 (18.4%) patients. The most common interventions were continuous positive airway pressure (CPAP) in 25/304 patients (8.2%) and jaw thrust in 15/304 (4.9%). The median induction propofol dose was 4.7 mg/kg. A need for an increase in the propofol infusion rate during the procedure was noted in 162/304 (53.3%) infants. No significant predictors of sedation-related adverse events were detected.
CONCLUSION: Propofol can be used for radiologic imaging of infants younger than 6 months of age with a high success rate. Practitioners should be mindful of significantly higher dosing requirements and a higher incidence of airway events, which can be easily identified and managed by a team of experienced sedation providers.
引用
- Jenkins E, Hebbar KB, Karaga KK, et al. Experience with the use of propofol for radiologic imaging in infants younger than 6 months of age. Pediatr Radiol. 2017. PMID: 28488002. doi:10.1007/s00247-017-3844-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。